Health economics and outcomes research (HEOR) in the pharmaceutical industry
This critical function supports successful drug launches in an increasingly competitive landscape.
Lance Hill in PharmExec: a bright future for medical affairs
Within3’s CEO shares how technology offers a tech-enabled way forward.
Value in virtual: new recommendations for KOL engagement
What are the new best practices for engaging KOLs and building successful relationships?
Ultimate Guide to Healthcare Conferences
Health conferences provide avenues for disseminating the latest scientific and medical insights to stakeholders. And in an industry where up-to-date information is oxygen, these yearly meetings breathe life into the industry and ensure HCPs, researchers, and medical affairs teams are equipped to improve and optimize care.
What’s on the mind of medical affairs?
Questions raised at Reuters Pharma Europe reveal what medical affairs is prioritizing for 2023.
Medical affairs takes over: lessons from Reuters Pharma
How will technology enable medical affairs to lead their organizations more effectively?
Within3 in Journal of mHealth: operational excellence in medical affairs
The time is right for medical affairs to address vulnerabilities in existing operating models and invest in technologies that strengthen the organization.
One to watch: medical affairs thought leaders discuss launch excellence
Industry experts with Novartis, Genentech, and Myovant Sciences share why an insights management strategy is critical to launch success.
How better insights can help medical affairs teams gain strategic ground
Medical affairs teams are up against a rapidly changing landscape, but there are tools to help them get ahead.
The strategy behind a better KOL experience
Here’s how insights management technology provides better results for you and a great experience for your KOLs.